Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. / Bøttger, Pernille; Glerup, Simon; Gesslein, Bodil; Illarionova, Nina B; Isaksen, Toke J; Heuck, Anders; Clausen, Bettina H; Füchtbauer, Ernst-Martin; Gramsbergen, Jan B; Gunnarson, Eli; Aperia, Anita; Lauritzen, Martin; Lambertsen, Kate L; Nissen, Poul; Lykke-Hartmann, Karin.

I: Scientific Reports, Bind 6, 22047, 25.02.2016.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bøttger, P, Glerup, S, Gesslein, B, Illarionova, NB, Isaksen, TJ, Heuck, A, Clausen, BH, Füchtbauer, E-M, Gramsbergen, JB, Gunnarson, E, Aperia, A, Lauritzen, M, Lambertsen, KL, Nissen, P & Lykke-Hartmann, K 2016, 'Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model', Scientific Reports, bind 6, 22047. https://doi.org/10.1038/srep22047

APA

Bøttger, P., Glerup, S., Gesslein, B., Illarionova, N. B., Isaksen, T. J., Heuck, A., Clausen, B. H., Füchtbauer, E-M., Gramsbergen, J. B., Gunnarson, E., Aperia, A., Lauritzen, M., Lambertsen, K. L., Nissen, P., & Lykke-Hartmann, K. (2016). Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Scientific Reports, 6, [22047]. https://doi.org/10.1038/srep22047

Vancouver

Bøttger P, Glerup S, Gesslein B, Illarionova NB, Isaksen TJ, Heuck A o.a. Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Scientific Reports. 2016 feb. 25;6. 22047. https://doi.org/10.1038/srep22047

Author

Bøttger, Pernille ; Glerup, Simon ; Gesslein, Bodil ; Illarionova, Nina B ; Isaksen, Toke J ; Heuck, Anders ; Clausen, Bettina H ; Füchtbauer, Ernst-Martin ; Gramsbergen, Jan B ; Gunnarson, Eli ; Aperia, Anita ; Lauritzen, Martin ; Lambertsen, Kate L ; Nissen, Poul ; Lykke-Hartmann, Karin. / Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. I: Scientific Reports. 2016 ; Bind 6.

Bibtex

@article{4c513babf1704e539d7045fe207ada92,
title = "Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model",
abstract = "Migraine is a complex brain disorder, and understanding the complexity of this prevalent disease could improve quality of life for millions of people. Familial Hemiplegic Migraine type 2 (FHM2) is a subtype of migraine with aura and co-morbidities like epilepsy/seizures, cognitive impairments and psychiatric manifestations, such as obsessive-compulsive disorder (OCD). FHM2 disease-mutations locate to the ATP1A2 gene encoding the astrocyte-located α2-isoform of the sodium-potassium pump (α2Na(+)/K(+)-ATPase). We show that knock-in mice heterozygous for the FHM2-associated G301R-mutation (α2(+/G301R)) phenocopy several FHM2-relevant disease traits e.g., by mimicking mood depression and OCD. In vitro studies showed impaired glutamate uptake in hippocampal mixed astrocyte-neuron cultures from α2(G301R/G301R) E17 embryonic mice, and moreover, induction of cortical spreading depression (CSD) resulted in reduced recovery in α2(+/G301R) male mice. Moreover, NMDA-type glutamate receptor antagonists or progestin-only treatment reverted specific α2(+/G301R) behavioral phenotypes. Our findings demonstrate that studies of an in vivo relevant FHM2 disease knock-in mouse model provide a link between the female sex hormone cycle and the glutamate system and a link to co-morbid psychiatric manifestations of FHM2.",
author = "Pernille B{\o}ttger and Simon Glerup and Bodil Gesslein and Illarionova, {Nina B} and Isaksen, {Toke J} and Anders Heuck and Clausen, {Bettina H} and Ernst-Martin F{\"u}chtbauer and Gramsbergen, {Jan B} and Eli Gunnarson and Anita Aperia and Martin Lauritzen and Lambertsen, {Kate L} and Poul Nissen and Karin Lykke-Hartmann",
year = "2016",
month = feb,
day = "25",
doi = "10.1038/srep22047",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model

AU - Bøttger, Pernille

AU - Glerup, Simon

AU - Gesslein, Bodil

AU - Illarionova, Nina B

AU - Isaksen, Toke J

AU - Heuck, Anders

AU - Clausen, Bettina H

AU - Füchtbauer, Ernst-Martin

AU - Gramsbergen, Jan B

AU - Gunnarson, Eli

AU - Aperia, Anita

AU - Lauritzen, Martin

AU - Lambertsen, Kate L

AU - Nissen, Poul

AU - Lykke-Hartmann, Karin

PY - 2016/2/25

Y1 - 2016/2/25

N2 - Migraine is a complex brain disorder, and understanding the complexity of this prevalent disease could improve quality of life for millions of people. Familial Hemiplegic Migraine type 2 (FHM2) is a subtype of migraine with aura and co-morbidities like epilepsy/seizures, cognitive impairments and psychiatric manifestations, such as obsessive-compulsive disorder (OCD). FHM2 disease-mutations locate to the ATP1A2 gene encoding the astrocyte-located α2-isoform of the sodium-potassium pump (α2Na(+)/K(+)-ATPase). We show that knock-in mice heterozygous for the FHM2-associated G301R-mutation (α2(+/G301R)) phenocopy several FHM2-relevant disease traits e.g., by mimicking mood depression and OCD. In vitro studies showed impaired glutamate uptake in hippocampal mixed astrocyte-neuron cultures from α2(G301R/G301R) E17 embryonic mice, and moreover, induction of cortical spreading depression (CSD) resulted in reduced recovery in α2(+/G301R) male mice. Moreover, NMDA-type glutamate receptor antagonists or progestin-only treatment reverted specific α2(+/G301R) behavioral phenotypes. Our findings demonstrate that studies of an in vivo relevant FHM2 disease knock-in mouse model provide a link between the female sex hormone cycle and the glutamate system and a link to co-morbid psychiatric manifestations of FHM2.

AB - Migraine is a complex brain disorder, and understanding the complexity of this prevalent disease could improve quality of life for millions of people. Familial Hemiplegic Migraine type 2 (FHM2) is a subtype of migraine with aura and co-morbidities like epilepsy/seizures, cognitive impairments and psychiatric manifestations, such as obsessive-compulsive disorder (OCD). FHM2 disease-mutations locate to the ATP1A2 gene encoding the astrocyte-located α2-isoform of the sodium-potassium pump (α2Na(+)/K(+)-ATPase). We show that knock-in mice heterozygous for the FHM2-associated G301R-mutation (α2(+/G301R)) phenocopy several FHM2-relevant disease traits e.g., by mimicking mood depression and OCD. In vitro studies showed impaired glutamate uptake in hippocampal mixed astrocyte-neuron cultures from α2(G301R/G301R) E17 embryonic mice, and moreover, induction of cortical spreading depression (CSD) resulted in reduced recovery in α2(+/G301R) male mice. Moreover, NMDA-type glutamate receptor antagonists or progestin-only treatment reverted specific α2(+/G301R) behavioral phenotypes. Our findings demonstrate that studies of an in vivo relevant FHM2 disease knock-in mouse model provide a link between the female sex hormone cycle and the glutamate system and a link to co-morbid psychiatric manifestations of FHM2.

U2 - 10.1038/srep22047

DO - 10.1038/srep22047

M3 - Journal article

C2 - 26911348

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 22047

ER -

ID: 167472653